Skip to content
10-Q

Quarterly Report

DAY ONE BIOPHARMACEUTICALS, INC.

0001193125-25-264649

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 102.68M sh
Shares Diluted Q3 2025 · Sep 30, 2025 103.38M sh
Shares Diluted Q3 2025 · Sep 30, 2025 103.06M sh
Shares Diluted Q3 2025 · Sep 30, 2024 96.94M sh
Shares Diluted Q3 2025 · Sep 30, 2024 90.16M sh
Capex Q3 2025 · Sep 30, 2025 $320K
Capex Q3 2025 · Sep 30, 2024 $750K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$89.61M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$48.11M
Short Term Investments Q3 2025 · Sep 30, 2025 $408.3M
Short Term Investments Q3 2025 · Dec 31, 2024 $406.75M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $43.28M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $124.97M
Stockholders Equity Q3 2025 · Sep 30, 2025 $450.87M
Stockholders Equity Q3 2025 · Jun 30, 2025 $460.83M
Stockholders Equity Q3 2025 · Mar 31, 2025 $479.51M
Stockholders Equity Q3 2025 · Dec 31, 2024 $502.75M
Stockholders Equity Q3 2025 · Sep 30, 2024 $555.46M
Stockholders Equity Q3 2025 · Jun 30, 2024 $306.73M
Stockholders Equity Q3 2025 · Mar 31, 2024 $296.81M
Stockholders Equity Q3 2025 · Dec 31, 2023 $346.54M
Current Liabilities Q3 2025 · Sep 30, 2025 $56.47M
Current Liabilities Q3 2025 · Dec 31, 2024 $73.45M
Total Liabilities Q3 2025 · Sep 30, 2025 $62.91M
Total Liabilities Q3 2025 · Dec 31, 2024 $80.04M
Current Assets Q3 2025 · Sep 30, 2025 $489.97M
Current Assets Q3 2025 · Dec 31, 2024 $562.33M
Total Assets Q3 2025 · Sep 30, 2025 $513.78M
Total Assets Q3 2025 · Dec 31, 2024 $582.79M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.19
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.83
Eps Diluted Q3 2025 · Sep 30, 2024 $0.38
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.33
Eps Basic Q3 2025 · Sep 30, 2025 −$0.19
Eps Basic Q3 2025 · Sep 30, 2025 −$0.83
Eps Basic Q3 2025 · Sep 30, 2024 $0.38
Eps Basic Q3 2025 · Sep 30, 2024 −$0.33
Sga Expense Q3 2025 · Sep 30, 2025 $28.15M
Sga Expense Q3 2025 · Sep 30, 2025 $86.44M
Sga Expense Q3 2025 · Sep 30, 2024 $28.97M
Sga Expense Q3 2025 · Sep 30, 2024 $85.72M
Rd Expense Q3 2025 · Sep 30, 2025 $31.42M
Rd Expense Q3 2025 · Sep 30, 2025 $107.19M
Rd Expense Q3 2025 · Sep 30, 2024 $33.56M
Rd Expense Q3 2025 · Sep 30, 2024 $165.88M
Net Income Q3 2025 · Sep 30, 2025 −$19.73M
Net Income Q3 2025 · Sep 30, 2025 −$86.04M
Net Income Q3 2025 · Jun 30, 2025 −$30.32M
Net Income Q3 2025 · Mar 31, 2025 −$36M
Net Income Q3 2025 · Sep 30, 2024 $37.04M
Net Income Q3 2025 · Sep 30, 2024 −$29.78M
Net Income Q3 2025 · Jun 30, 2024 −$4.41M
Net Income Q3 2025 · Mar 31, 2024 −$62.41M
Operating Income Q3 2025 · Sep 30, 2025 −$24.25M
Operating Income Q3 2025 · Sep 30, 2025 −$100.29M
Operating Income Q3 2025 · Sep 30, 2024 $29.64M
Operating Income Q3 2025 · Sep 30, 2024 −$151.94M
Revenue Q3 2025 · Sep 30, 2025 $39.8M
Revenue Q3 2025 · Sep 30, 2025 $104.46M
Revenue Q3 2025 · Sep 30, 2024 $93.76M
Revenue Q3 2025 · Sep 30, 2024 $101.95M